Core Viewpoint - Wanrun Co., Ltd. has experienced a stock price decline of 2.03% on December 30, with a current price of 14.95 CNY per share and a market capitalization of 13.798 billion CNY. The company has seen a year-to-date stock price increase of 25.63% but a recent decline of 8.73% over the last five trading days [1]. Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. achieved a revenue of 2.826 billion CNY, representing a year-on-year growth of 2.31%. The net profit attributable to shareholders was 306 million CNY, reflecting a year-on-year increase of 3.27% [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Wanrun Co., Ltd. was 42,100, a decrease of 13.28% from the previous period. The average number of circulating shares per person increased by 15.31% to 21,575 shares [2]. Dividend Distribution - Since its A-share listing, Wanrun Co., Ltd. has distributed a total of 2.005 billion CNY in dividends. Over the past three years, the cumulative dividend payout has been 646 million CNY [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder, holding 12.2602 million shares, an increase of 3.6845 million shares from the previous period. Additionally, GF Multi-Factor Mixed Fund (002943) entered as the tenth largest circulating shareholder with 10.8781 million shares [3].

Core Viewpoint - Wanrun Co., Ltd. has shown a positive stock performance with a year-to-date increase of 19.16% and a recent 5-day increase of 10.69%, indicating strong market interest and potential growth in the electronic materials sector [1][2]. Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. achieved a revenue of 2.826 billion yuan, representing a year-on-year growth of 2.31%. The net profit attributable to shareholders was 306 million yuan, reflecting a growth of 3.27% compared to the previous year [2]. - The company has distributed a total of 2.005 billion yuan in dividends since its A-share listing, with 646 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Wanrun Co., Ltd. was 42,100, a decrease of 13.28% from the previous period. The average number of circulating shares per shareholder increased by 15.31% to 21,575 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 12.2602 million shares, an increase of 3.6845 million shares from the previous period. Additionally, GF Multi-Factor Mixed Fund has entered as a new shareholder with 10.8781 million shares [3]. Market Activity - On November 28, Wanrun Co., Ltd. saw its stock price rise by 2.09%, reaching 14.18 yuan per share, with a trading volume of 237 million yuan and a turnover rate of 1.86%. The total market capitalization stood at 13.088 billion yuan [1]. - The net inflow of main funds was 8.8729 million yuan, with significant buying activity from large orders amounting to 39.9358 million yuan, indicating strong investor interest [1]. Business Overview - Wanrun Co., Ltd. is located in Yantai, Shandong Province, and was established on July 5, 1995. It was listed on December 20, 2011. The company operates in three main sectors: electronic information materials, environmental protection materials, and health products, with functional materials accounting for 78.58% of its revenue [1]. - The company is classified under the Shenwan industry as electronic-chemical products, with involvement in sectors such as electronic chemicals, exhaust treatment, lithium batteries, new materials, and solid-state batteries [1].

Company Overview - Wanrun Co., Ltd. is located in Yantai Economic and Technological Development Zone, Shandong Province, established on July 5, 1995, and listed on December 20, 2011 [1] - The company operates in three main business areas: electronic information materials, environmental protection materials, and health industry products, with revenue composition being 78.58% from functional materials, 20.09% from life sciences and pharmaceuticals, and 1.33% from other sources [1] Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. achieved a revenue of 2.826 billion yuan, representing a year-on-year growth of 2.31%, and a net profit attributable to shareholders of 306 million yuan, up 3.27% year-on-year [2] - Since its A-share listing, the company has distributed a total of 2.005 billion yuan in dividends, with 646 million yuan distributed over the past three years [3] Stock Performance - As of November 5, Wanrun's stock price decreased by 2.06%, trading at 13.32 yuan per share, with a total market capitalization of 12.294 billion yuan [1] - Year-to-date, the stock price has increased by 11.93%, but it has seen a decline of 4.79% over the last five trading days and a decrease of 3.13% over the last 20 days [1] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.28% to 42,100, while the average number of circulating shares per person increased by 15.31% to 21,575 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the ninth largest with 12.2602 million shares, an increase of 3.6845 million shares from the previous period [3]

Core Points - Wanrun Co., Ltd. experienced a stock price decline of 2.02% on November 4, trading at 13.61 CNY per share with a market capitalization of 12.561 billion CNY [1] - The company has seen a year-to-date stock price increase of 14.37%, but a decline of 2.65% over the last five trading days [1] Financial Performance - For the period from January to September 2025, Wanrun Co., Ltd. reported a revenue of 2.826 billion CNY, representing a year-on-year growth of 2.31% [2] - The net profit attributable to shareholders for the same period was 306 million CNY, reflecting a year-on-year increase of 3.27% [2] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.28% to 42,100, while the average number of circulating shares per person increased by 15.31% to 21,575 shares [2] - The company has distributed a total of 2.005 billion CNY in dividends since its A-share listing, with 646 million CNY distributed over the past three years [3] Ownership Structure - As of September 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder, increasing its holdings by 3.6845 million shares to 12.2602 million shares [3] - Guangfa Multi-Factor Mixed Fund became a new shareholder, holding 10.8781 million shares, ranking as the tenth largest circulating shareholder [3]

Group 1 - The core viewpoint of the news is that Wanrun Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.11% to 13.79 CNY per share, and a total market capitalization of 12.728 billion CNY [1] - Wanrun Co., Ltd. is engaged in three main business areas: electronic information materials, environmental protection materials, and health industry products, with functional materials accounting for 78.58% of revenue, life sciences and pharmaceuticals for 20.09%, and other categories for 1.33% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Wanrun Co., Ltd., specifically the Galaxy New Materials Stock Initiation A (020276), which reduced its holdings by 5,800 shares in the second quarter, maintaining 53,700 shares, representing 5.26% of the fund's net value [2] - The Galaxy New Materials Stock Initiation A (020276) has achieved a year-to-date return of 32.29%, ranking 1479 out of 4220 in its category, and a one-year return of 62.93%, ranking 1436 out of 3814 [2] - The fund manager of Galaxy New Materials Stock Initiation A is Jin Ye, who has been in the position for approximately 3 years and 265 days, with the fund's total asset size at 54.3398 million CNY [3]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company's performance improved in the first half of 2025, with a year-on-year increase in net profit despite a slight decline in revenue. The second quarter showed a significant recovery in profitability [2][4]. - The company is actively expanding its production capacity in new materials, particularly in semiconductor manufacturing materials, which is expected to drive future growth [3][4]. Financial Performance Summary - In the first half of 2025, the company achieved revenue of 1.87 billion, a year-on-year decrease of 4.42%, while net profit attributable to shareholders was 218 million, an increase of 1.35% [2][6]. - For Q2 2025, revenue was 1.01 billion, with a year-on-year increase of 17.12%, and net profit was 138 million, reflecting a significant quarter-on-quarter growth of 73.13% [2][6]. - The gross margin for Q2 2025 was 39.77%, showing an improvement compared to previous periods, while the net margin reached 16.02% [2][3]. Business Segment Performance - The functional materials segment generated revenue of 1.47 billion, down 9.55% year-on-year, while the life sciences and pharmaceutical products segment saw a revenue increase of 20.80% to 376 million [2][3]. - The company is focusing on high-performance polymer products, with PEEK materials already in trial production and ongoing market promotion [3]. Future Outlook - The company expects to achieve net profits of 434 million, 519 million, and 581 million for the years 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 29.23, 24.44, and 21.80 [4][10]. - The ongoing construction of the new materials project is 55% complete, with plans to add 7,900 tons/year of functional materials capacity, which is anticipated to start production within the year [3][4].